# More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges

Study · id `cardio:ct-nct01510652` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01510652](<https://clinicaltrials.gov/study/NCT01510652>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01510652

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1078 participants.

## Technical summary

Registry record NCT01510652. Randomized; no masking; primary purpose prevention. Start 2011-11 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2015-10-23.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1078 participants (enrolled count; ClinicalTrials.gov record NCT01510652, source copy `cardio:ctgov-nct01510652-2019-02-15`, retrieved 2026-10-26)
- Start date: 2011-11 (registry gives no type) (ClinicalTrials.gov record NCT01510652, source copy `cardio:ctgov-nct01510652-2019-02-15`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01510652, source copy `cardio:ctgov-nct01510652-2019-02-15`, retrieved 2026-10-26)
- Completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01510652, source copy `cardio:ctgov-nct01510652-2019-02-15`, retrieved 2026-10-26)
- Results first posted: 2015-10-23 (ClinicalTrials.gov record NCT01510652, source copy `cardio:ctgov-nct01510652-2019-02-15`, retrieved 2026-10-26)
- Countries: Belgium; Canada; Finland; France; Germany; India; Israel; Italy; Netherlands; Poland; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT01510652, source copy `cardio:ctgov-nct01510652-2019-02-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01510652-2019-02-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges
- Acronym: MORE-CRT
- Condition: Postoperative Cardiac Complication
- Condition: Heart Failure
- Condition: Left Ventricular Cardiac Dysfunction
- Condition: Inappropriate Phrenic Nerve Stimulation
- Condition: Perioperative/Postoperative Complications
- Intervention (Procedure): BiP Group
- Intervention (Device): Quad Group
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 9cc400aaee0412d93c15a4fa414ab309f3ce6ff6aaad00365e6671a5e87ddbc4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
